Infinity Pharmaceuticals is in post-confirmation liquidation, with $2,630,126 paid to general unsecured creditors through June 30, 2026, according to the trust’s post-confirmation report Dkt. 452. The next dated milestone is the November 13, 2026 claims-objection deadline, established by the July 31, 2026 extension order Dkt. 455, as the trustee continues claims reconciliation.

Infinity Pharmaceuticals is in post-confirmation liquidation, with $2,630,126 paid to general unsecured creditors through June 30, 2026, according to the trust’s post-confirmation report Dkt. 452. The next dated milestone is the November 13, 2026 claims-objection deadline, established by the July 31, 2026 extension order Dkt. 455, as the trustee continues claims reconciliation.